Climea Forte
Natural health product licensed in Canada
- Other names
- Climea
- Licence holder
- Kaborex Inc.
- NPN or DIN-HM
- 80097299
- Status
- Active licence
- Licence date
- 26 February 2020
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitamine E Source : Succinate d'acide de d-alpha tocophéryle | 12 mcg AT | Not calculated |
| Humulus lupulus Source : Strobiles | 30 mg | Not calculated |
| Calcium Source : Calcium carbonate | 400 mg | Not calculated |
| Folate Source : Acide folique | 200 mcg | Not calculated |
Non-medicinal ingredients
N° 15985, Cire de Carnauba, Jaune de quinoléine (E104), Hyprolose, Cellulose, Hypromellose, Sels de magnésium d'acides gras, Cire d'abeille blanche, Carmellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Femmes ménopausées et en postménopause | Not specified | minimum: 1 Comprimé ; maximum: 2 Comprimé | 1 Tous les jours |
Uses authorised in Canada
Helps in the development and maintenance of bones. Helps to maintain the body's ability to metabolize nutrients. May reduce severe and frequent menopausal symptoms (such as hot flashes and/or night sweats).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not use this product if you currently have or previously had breast cancer and/or breast tumours or if you have a predisposition to breast cancer, as indicated by an abnormal mammogram and/or biopsy, or a family member with breast cancer.
- Effets indésirables connus
Stop use if hypersensitivity/allergy occurs. Some people may experience drowsiness. Exercise caution if operating heavy machinery, driving a motor vehicle or involved in activities requiring mental alertness.
Source
Official Health Canada record, licence 80097299
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.